---
title: 'FDA Public Meetings #2: Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Lessons Learned about Data Collection and Analysis'
author: ''
date: '2022-07-25T08:00:00'
slug: fda-public-meetings-2-using-methods-from-pfdd
categories: []
tags: []
type: webinar
url_freeregister: https://www.eventbrite.com/e/patient-experience-data-in-clinical-trials-lessons-learned-tickets-363026190107
url_register: ~
url_slides: ~
url_video: no
url_agenda: ~
url_website: ~
url_audio: ~
url_code: ~
url_pdf: ~
date_end: '2022-07-25T10:00:00'
all_day: no
publishDate: '2022-06-22T10:08:09-07:00'
featured: no
image:
  caption: ''
  focal_point: ''
  preview_only: no
slides: ''
projects: []
location: ~
address:
  street: ~
  city: ~
  region: ~
  postcode: ~
  country: ~
summary: ~
abstract: ~
speaker: ~
---

<!--more-->
Speakers and participants will discuss a range of issues data collection and analysis, focusing on lessons learned and on areas identified as particularly challenging for stakeholders. You may find a link to the referenced guidance documents here: [PFDD Methodologic Guidance Documents](http://wcms-internet.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical?utm_medium=email&utm_source=govdelivery)